Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 03, 2022

SELL
$24.0 - $33.42 $271,200 - $377,646
-11,300 Closed
0 $0
Q2 2022

Jul 01, 2022

BUY
$24.78 - $33.36 $280,014 - $376,968
11,300 New
11,300 $286,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $819M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Rempart Asset Management Inc. Portfolio

Follow Rempart Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rempart Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rempart Asset Management Inc. with notifications on news.